PLK1 and glioblastoma: PLK4 mRNA and protein are overexpressed in glioblastoma; PLK4 promotes proliferation and tumorigenesis; increased PLK4 expression is associated with poor prognosis; PLK knockdown increases radiosensitivity and sensitivity to temozolomide and bortezomib.